Format

Send to

Choose Destination
Neuropsychopharmacology. 2017 May;42(6):1179-1181. doi: 10.1038/npp.2016.193. Epub 2016 Sep 19.

Balancing the Promise and Risks of Ketamine Treatment for Mood Disorders.

Author information

1
Yale Depression Research Program, Yale University School of Medicine, New Haven, CT, USA.
2
Cure Alliance for Mental Illness, Providence, RI, USA.
3
Ketamine Advocacy Network, Seattle, WA, USA.
4
Baylor College of Medicine, Houston, TX and Michael E. Debakey VA Medical Center, Houston, TX, USA.
5
Mayo Clinic, Rochester, MN, USA.
6
University of Miami, Miami FL, USA.
7
Blue Cross of Idaho, Boise, ID, USA.

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center